|
13 Companies |
|
11 Products |
|
11 Products |
|
18 Mechanisms of Action |
|
0 Trials |
|
19 News |
|
- | Trial completion, Enrollment change: The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study (clinicaltrials.gov) - Sep 25, 2017
P=N/A, N=40, Completed, Sponsor: Ohio State University
Active, not recruiting --> Completed | N=80 --> 40
- sodium valproate / Generic mfg.
Phase classification: Effect of Valproic Acid Concentration on Photic Response (clinicaltrials.gov) - Jun 14, 2017
P4, N=13, Completed, Sponsor: Vanderbilt University Medical Center
Active, not recruiting --> Completed | N=80 --> 40 Phase classification: P=N/A --> P4
- Enrollment closed, Trial primary completion date: The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study (clinicaltrials.gov) - Oct 23, 2014
P=N/A, N=80, Active, not recruiting, Sponsor: Ohio State University
Phase classification: P=N/A --> P4 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Dec 2014
- lenalidomide / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: LENAKAP: Lenalidomide in Kaposi Disease Associated With HIV Infection (clinicaltrials.gov) - Aug 1, 2014
P2, N=12, Terminated, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Dec 2014 N=35 --> 12 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2013 --> Feb 2014
- Photofrin (porfimer sodium) / Advanz Pharma
Trial withdrawal: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light (clinicaltrials.gov) - Feb 27, 2014
P2, N=0, Withdrawn, Sponsor: Pinnacle Biologics Inc.
N=35 --> 12 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2013 --> Feb 2014 Not yet recruiting --> Withdrawn
- Photofrin (porfimer sodium) / Advanz Pharma
Enrollment change: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light (clinicaltrials.gov) - Feb 27, 2014
P2, N=0, Withdrawn, Sponsor: Pinnacle Biologics Inc.
Not yet recruiting --> Withdrawn N=20 --> 0
- Trial completion: Skin Aging in Renal Transplant Patients (clinicaltrials.gov) - Feb 19, 2014
P4, N=100, Completed, Sponsor: University of Zurich
N=20 --> 0 Enrolling by invitation --> Completed
- Enrollment open: The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study (clinicaltrials.gov) - Sep 12, 2013
P=N/A, N=80, Recruiting, Sponsor: Ohio State University
Enrolling by invitation --> Completed Not yet recruiting --> Recruiting
- Trial completion: The Sun Protective Effect of Melatonin (clinicaltrials.gov) - Aug 27, 2013
P1, N=22, Completed, Sponsor: Herlev Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed
- | lenalidomide / Generic mfg.
Enrollment closed: LENAKAP: Lenalidomide in Kaposi Disease Associated With HIV Infection (clinicaltrials.gov) - Jul 16, 2013
P2, N=35, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting --> Completed Recruiting --> Active, not recruiting
- New P1 trial: The Sun Protective Effect of Melatonin (clinicaltrials.gov) - Jun 6, 2013
P1, N=22, Completed, Sponsor: Herlev Hospital
- Photofrin (porfimer sodium) / Advanz Pharma
Trial initiation date: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light (clinicaltrials.gov) - Feb 17, 2013
P2, N=0, Withdrawn, Sponsor: Pinnacle Biologics Inc.
Recruiting --> Active, not recruiting Initiation date: Jul 2012 --> May 2013
- | New P4 trial: Skin Aging in Renal Transplant Patients (clinicaltrials.gov) - Jan 24, 2013
P4, N=100, Completed, Sponsor: University of Zurich
- ICA-105665 / Pfizer
Trial termination: A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients (clinicaltrials.gov) - Sep 26, 2012
P2, N=13, Terminated, Sponsor: Pfizer
Initiation date: Jul 2012 --> May 2013 Completed --> Terminated; The study was terminated on September 12, 2010 per protocol following a serious adverse event that occurred with the first subject dosed at 600 mg.
- levetiracetam / Generic mfg., carbamazepine / Generic mfg.
Trial completion: Photosensitivity Proof of Concept Trial (clinicaltrials.gov) - Feb 29, 2012
P2, N=6, Completed, Sponsor: The Epilepsy Study Consortium
Completed --> Terminated; The study was terminated on September 12, 2010 per protocol following a serious adverse event that occurred with the first subject dosed at 600 mg. Active, not recruiting --> Completed
- | lenalidomide / Generic mfg.
Trial initiation date: LENAKAP: Lenalidomide in Kaposi Disease Associated With HIV Infection (clinicaltrials.gov) - Dec 8, 2011
P2, N=35, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Active, not recruiting --> Completed Initiation date: Jul 2011 --> Oct 2011
- Enrollment change: Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients (clinicaltrials.gov) - Aug 17, 2011
P4, N=25, Completed, Sponsor: University of Zurich
Initiation date: Jul 2011 --> Oct 2011 N=2009 --> 25
- Trial completion: Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients (clinicaltrials.gov) - Aug 17, 2011
P4, N=25, Completed, Sponsor: University of Zurich
N=2009 --> 25 Active, not recruiting --> Completed
- Trial completion: Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head (clinicaltrials.gov) - Aug 17, 2011
P4, N=418, Completed, Sponsor: University Hospital Tuebingen
Active, not recruiting --> Completed Active, not recruiting --> Completed